ID   AT11C_HUMAN             Reviewed;        1132 AA.
AC   Q8NB49; Q5JT69; Q5JT70; Q5JT71; Q5JT72; Q5JT73; Q6ZND5; Q6ZU50;
AC   Q6ZUP7; Q70IJ9; Q70IK0; Q8WX24;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   12-APR-2017, entry version 145.
DE   RecName: Full=Phospholipid-transporting ATPase IG;
DE            EC=3.6.3.1;
DE   AltName: Full=ATPase IQ;
DE   AltName: Full=ATPase class VI type 11C;
DE   AltName: Full=P4-ATPase flippase complex alpha subunit ATP11C;
GN   Name=ATP11C; Synonyms=ATPIG, ATPIQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), TISSUE SPECIFICITY, AND
RP   VARIANT TRP-114.
RC   TISSUE=Liver;
RX   PubMed=15533723; DOI=10.1016/j.ygeno.2004.08.003;
RA   Andrew-Nesbit M., Bowl M.R., Harding B., Schlessinger D., Whyte M.P.,
RA   Thakker R.V.;
RT   "X-linked hypoparathyroidism region on Xq27 is evolutionarily
RT   conserved with regions on 3q26 and 13q34 and contains a novel P-type
RT   ATPase.";
RL   Genomics 84:1060-1070(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 305-1132 (ISOFORM 4),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 543-1132 (ISOFORM 1), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 777-1132 (ISOFORM 2).
RC   TISSUE=Brain, Fetal brain, Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1108, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   INTERACTION WITH TMEM30A, AND SUBCELLULAR LOCATION.
RX   PubMed=21914794; DOI=10.1074/jbc.M111.281006;
RA   Takatsu H., Baba K., Shima T., Umino H., Kato U., Umeda M.,
RA   Nakayama K., Shin H.W.;
RT   "ATP9B, a P4-ATPase (a putative aminophospholipid translocase),
RT   localizes to the trans-Golgi network in a CDC50 protein-independent
RT   manner.";
RL   J. Biol. Chem. 286:38159-38167(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445; SER-1108; SER-1116
RP   AND SER-1126, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-157 AND PRO-931.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Catalytic component of a P4-ATPase flippase complex
CC       which catalyzes the hydrolysis of ATP coupled to the transport of
CC       aminophospholipids from the outer to the inner leaflet of various
CC       membranes and ensures the maintenance of asymmetric distribution
CC       of phospholipids. Phospholipid translocation seems also to be
CC       implicated in vesicle formation and in uptake of lipid signaling
CC       molecules. Required for B cell differentiation past the pro-B cell
CC       stage. Seems to mediate phosphatidylserine (PS) flipping in pro-B
CC       cells. May be involved in the transport of cholestatic bile acids
CC       (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + phospholipid(Side 1) = ADP +
CC       phosphate + phospholipid(Side 2).
CC   -!- SUBUNIT: Component of a P4-ATPase flippase complex which consists
CC       of a catalytic alpha subunit and an accessory beta subunit
CC       (Probable). Interacts with beta subunit TMEM30A.
CC       {ECO:0000269|PubMed:21914794, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21914794};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21914794}.
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:21914794}.
CC       Note=Efficient exit from the endoplasmic reticulum requires the
CC       presence of TMEM30A. Some cell membrane localization observed in
CC       the presence of TMEM30B.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NB49-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NB49-2; Sequence=VSP_007309;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8NB49-3; Sequence=VSP_013373;
CC       Name=4;
CC         IsoId=Q8NB49-4; Sequence=VSP_013374;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:15533723}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IV subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03692.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC86172.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC86377.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD18440.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAI39713.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI39714.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI39716.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI40418.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41444.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41445.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41446.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41447.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ580093; CAE30472.1; -; mRNA.
DR   EMBL; AJ580094; CAE30473.1; -; mRNA.
DR   EMBL; AL161777; CAI39713.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356785; CAI39713.1; JOINED; Genomic_DNA.
DR   EMBL; AL161777; CAI39714.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356785; CAI39714.1; JOINED; Genomic_DNA.
DR   EMBL; AL161777; CAI39716.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356785; CAI39716.1; JOINED; Genomic_DNA.
DR   EMBL; AL590077; CAI39716.1; JOINED; Genomic_DNA.
DR   EMBL; AL356785; CAI41444.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161777; CAI41444.1; JOINED; Genomic_DNA.
DR   EMBL; AL356785; CAI41445.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161777; CAI41445.1; JOINED; Genomic_DNA.
DR   EMBL; AL356785; CAI41446.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL161777; CAI41446.1; JOINED; Genomic_DNA.
DR   EMBL; AL590077; CAI41446.1; JOINED; Genomic_DNA.
DR   EMBL; AL356785; CAI41447.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL590077; CAI40418.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL356785; CAI40418.1; JOINED; Genomic_DNA.
DR   EMBL; AL161777; CAI40418.1; JOINED; Genomic_DNA.
DR   EMBL; AK091552; BAC03692.1; ALT_INIT; mRNA.
DR   EMBL; AK125474; BAC86172.1; ALT_INIT; mRNA.
DR   EMBL; AK125986; BAC86377.1; ALT_INIT; mRNA.
DR   EMBL; AK131262; BAD18440.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14668.1; -. [Q8NB49-1]
DR   CCDS; CCDS35410.1; -. [Q8NB49-3]
DR   RefSeq; NP_001010986.1; NM_001010986.2.
DR   RefSeq; NP_775965.2; NM_173694.4.
DR   UniGene; Hs.88252; -.
DR   ProteinModelPortal; Q8NB49; -.
DR   BioGrid; 130370; 34.
DR   IntAct; Q8NB49; 4.
DR   STRING; 9606.ENSP00000332756; -.
DR   TCDB; 3.A.3.8.14; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; Q8NB49; -.
DR   PhosphoSitePlus; Q8NB49; -.
DR   SwissPalm; Q8NB49; -.
DR   BioMuta; ATP11C; -.
DR   DMDM; 62512178; -.
DR   EPD; Q8NB49; -.
DR   MaxQB; Q8NB49; -.
DR   PaxDb; Q8NB49; -.
DR   PeptideAtlas; Q8NB49; -.
DR   PRIDE; Q8NB49; -.
DR   DNASU; 286410; -.
DR   Ensembl; ENST00000327569; ENSP00000332756; ENSG00000101974. [Q8NB49-1]
DR   Ensembl; ENST00000361648; ENSP00000355165; ENSG00000101974. [Q8NB49-3]
DR   GeneID; 286410; -.
DR   KEGG; hsa:286410; -.
DR   UCSC; uc004faz.4; human. [Q8NB49-1]
DR   CTD; 286410; -.
DR   GeneCards; ATP11C; -.
DR   HGNC; HGNC:13554; ATP11C.
DR   HPA; HPA030830; -.
DR   MIM; 300516; gene.
DR   neXtProt; NX_Q8NB49; -.
DR   OpenTargets; ENSG00000101974; -.
DR   PharmGKB; PA25103; -.
DR   eggNOG; KOG0206; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00870000136387; -.
DR   HOVERGEN; HBG050601; -.
DR   InParanoid; Q8NB49; -.
DR   KO; K01530; -.
DR   OMA; WDKDFYD; -.
DR   OrthoDB; EOG091G03B1; -.
DR   PhylomeDB; Q8NB49; -.
DR   TreeFam; TF326897; -.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP11C; human.
DR   GenomeRNAi; 286410; -.
DR   PRO; PR:Q8NB49; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101974; -.
DR   ExpressionAtlas; Q8NB49; baseline and differential.
DR   Genevisible; Q8NB49; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004012; F:phospholipid-translocating ATPase activity; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0045332; P:phospholipid translocation; NAS:UniProtKB.
DR   GO; GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl.
DR   GO; GO:0002329; P:pre-B cell differentiation; IEA:Ensembl.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR030363; ATP11C.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006539; P-type_ATPase_IV.
DR   InterPro; IPR032631; P-type_ATPase_N.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR032630; P_typ_ATPase_c.
DR   PANTHER; PTHR24092; PTHR24092; 1.
DR   PANTHER; PTHR24092:SF133; PTHR24092:SF133; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   Pfam; PF16212; PhoLip_ATPase_C; 1.
DR   Pfam; PF16209; PhoLip_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01652; ATPase-Plipid; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 3.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Hydrolase; Lipid transport; Magnesium;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1132       Phospholipid-transporting ATPase IG.
FT                                /FTId=PRO_0000046373.
FT   TOPO_DOM      1     66       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     67     85       Helical. {ECO:0000255}.
FT   TOPO_DOM     86     86       Extracellular. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    290       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TOPO_DOM    312    346       Extracellular. {ECO:0000255}.
FT   TRANSMEM    347    367       Helical. {ECO:0000255}.
FT   TOPO_DOM    368    879       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    880    900       Helical. {ECO:0000255}.
FT   TOPO_DOM    901    908       Extracellular. {ECO:0000255}.
FT   TRANSMEM    909    929       Helical. {ECO:0000255}.
FT   TOPO_DOM    930    955       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    956    976       Helical. {ECO:0000255}.
FT   TOPO_DOM    977    995       Extracellular. {ECO:0000255}.
FT   TRANSMEM    996   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1026       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1027   1047       Helical. {ECO:0000255}.
FT   TOPO_DOM   1048   1069       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1070   1090       Helical. {ECO:0000255}.
FT   TOPO_DOM   1091   1132       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    412    412       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       819    819       Magnesium. {ECO:0000250}.
FT   METAL       823    823       Magnesium. {ECO:0000250}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1108   1108       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1116   1116       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1126   1126       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ    1100   1132       RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL -> VHHL
FT                                ISSSA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007309.
FT   VAR_SEQ    1100   1132       RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL -> NPNL
FT                                ELPMLLSYKHTDSGYS (in isoform 3).
FT                                {ECO:0000303|PubMed:15533723}.
FT                                /FTId=VSP_013373.
FT   VAR_SEQ    1100   1132       RNLSCRRASDSLSARPSVRPLLLRTFSDESNVL -> VTKR
FT                                LPSSGTSAIFMLSQTSSNHSFSWSE (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_013374.
FT   VARIANT     114    114       C -> W (in dbSNP:rs2491014).
FT                                {ECO:0000269|PubMed:15533723}.
FT                                /FTId=VAR_021827.
FT   VARIANT     157    157       T -> I (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036501.
FT   VARIANT     522    522       Y -> C (in dbSNP:rs17281983).
FT                                /FTId=VAR_055546.
FT   VARIANT     931    931       Q -> P (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036502.
FT   VARIANT     972    972       V -> M (in dbSNP:rs55724992).
FT                                /FTId=VAR_061036.
FT   CONFLICT    537    537       L -> P (in Ref. 3; BAC86377).
FT                                {ECO:0000305}.
FT   CONFLICT    873    873       I -> V (in Ref. 3; BAC86377).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1132 AA;  129477 MW;  74B63B20A5C6E49D CRC64;
     MQMVPSLPPA SECAGEEKRV GTRTVFVGNH PVSETEAYIA QRFCDNRIVS SKYTLWNFLP
     KNLFEQFRRI ANFYFLIIFL VQVTVDTPTS PVTSGLPLFF VITVTAIKQG YEDCLRHRAD
     NEVNKSTVYI IENAKRVRKE SEKIKVGDVV EVQADETFPC DLILLSSCTT DGTCYVTTAS
     LDGESNCKTH YAVRDTIALC TAESIDTLRA AIECEQPQPD LYKFVGRINI YSNSLEAVAR
     SLGPENLLLK GATLKNTEKI YGVAVYTGME TKMALNYQGK SQKRSAVEKS INAFLIVYLF
     ILLTKAAVCT TLKYVWQSTP YNDEPWYNQK TQKERETLKV LKMFTDFLSF MVLFNFIIPV
     SMYVTVEMQK FLGSFFISWD KDFYDEEINE GALVNTSDLN EELGQVDYVF TDKTGTLTEN
     SMEFIECCID GHKYKGVTQE VDGLSQTDGT LTYFDKVDKN REELFLRALC LCHTVEIKTN
     DAVDGATESA ELTYISSSPD EIALVKGAKR YGFTFLGNRN GYMRVENQRK EIEEYELLHT
     LNFDAVRRRM SVIVKTQEGD ILLFCKGADS AVFPRVQNHE IELTKVHVER NAMDGYRTLC
     VAFKEIAPDD YERINRQLIE AKMALQDREE KMEKVFDDIE TNMNLIGATA VEDKLQDQAA
     ETIEALHAAG LKVWVLTGDK METAKSTCYA CRLFQTNTEL LELTTKTIEE SERKEDRLHE
     LLIEYRKKLL HEFPKSTRSF KKAWTEHQEY GLIIDGSTLS LILNSSQDSS SNNYKSIFLQ
     ICMKCTAVLC CRMAPLQKAQ IVRMVKNLKG SPITLSIGDG ANDVSMILES HVGIGIKGKE
     GRQAARNSDY SVPKFKHLKK LLLAHGHLYY VRIAHLVQYF FYKNLCFILP QFLYQFFCGF
     SQQPLYDAAY LTMYNICFTS LPILAYSLLE QHINIDTLTS DPRLYMKISG NAMLQLGPFL
     YWTFLAAFEG TVFFFGTYFL FQTASLEENG KVYGNWTFGT IVFTVLVFTV TLKLALDTRF
     WTWINHFVIW GSLAFYVFFS FFWGGIIWPF LKQQRMYFVF AQMLSSVSTW LAIILLIFIS
     LFPEILLIVL KNVRRRSARR NLSCRRASDS LSARPSVRPL LLRTFSDESN VL
//
